Mutations in smooth muscle alpha-actin (ACTA2) cause coronary artery disease, stroke, and Moyamoya disease, along with thoracic aortic disease
- PMID: 19409525
- PMCID: PMC2680995
- DOI: 10.1016/j.ajhg.2009.04.007
Mutations in smooth muscle alpha-actin (ACTA2) cause coronary artery disease, stroke, and Moyamoya disease, along with thoracic aortic disease
Abstract
The vascular smooth muscle cell (SMC)-specific isoform of alpha-actin (ACTA2) is a major component of the contractile apparatus in SMCs located throughout the arterial system. Heterozygous ACTA2 mutations cause familial thoracic aortic aneurysms and dissections (TAAD), but only half of mutation carriers have aortic disease. Linkage analysis and association studies of individuals in 20 families with ACTA2 mutations indicate that mutation carriers can have a diversity of vascular diseases, including premature onset of coronary artery disease (CAD) and premature ischemic strokes (including Moyamoya disease [MMD]), as well as previously defined TAAD. Sequencing of DNA from patients with nonfamilial TAAD and from premature-onset CAD patients independently identified ACTA2 mutations in these patients and premature onset strokes in family members with ACTA2 mutations. Vascular pathology and analysis of explanted SMCs and myofibroblasts from patients harboring ACTA2 suggested that increased proliferation of SMCs contributed to occlusive diseases. These results indicate that heterozygous ACTA2 mutations predispose patients to a variety of diffuse and diverse vascular diseases, including TAAD, premature CAD, ischemic strokes, and MMD. These data demonstrate that diffuse vascular diseases resulting from either occluded or enlarged arteries can be caused by mutations in a single gene and have direct implications for clinical management and research on familial vascular diseases.
Figures
Similar articles
-
Mutations in smooth muscle alpha-actin (ACTA2) lead to thoracic aortic aneurysms and dissections.Nat Genet. 2007 Dec;39(12):1488-93. doi: 10.1038/ng.2007.6. Epub 2007 Nov 11. Nat Genet. 2007. PMID: 17994018
-
Clinical, pathological, and genetic analysis of a Korean family with thoracic aortic aneurysms and dissections carrying a novel Asp26Tyr mutation.Ann Clin Lab Sci. 2010 Summer;40(3):278-84. Ann Clin Lab Sci. 2010. PMID: 20689142
-
Vascular disease-causing mutation, smooth muscle α-actin R258C, dominantly suppresses functions of α-actin in human patient fibroblasts.Proc Natl Acad Sci U S A. 2017 Jul 11;114(28):E5569-E5578. doi: 10.1073/pnas.1703506114. Epub 2017 Jun 26. Proc Natl Acad Sci U S A. 2017. PMID: 28652363 Free PMC article.
-
Altered Smooth Muscle Cell Force Generation as a Driver of Thoracic Aortic Aneurysms and Dissections.Arterioscler Thromb Vasc Biol. 2017 Jan;37(1):26-34. doi: 10.1161/ATVBAHA.116.303229. Epub 2016 Nov 22. Arterioscler Thromb Vasc Biol. 2017. PMID: 27879251 Free PMC article. Review.
-
α-Smooth Muscle Actin and ACTA2 Gene Expressions in Vasculopathies.Braz J Cardiovasc Surg. 2015 Nov-Dec;30(6):644-9. doi: 10.5935/1678-9741.20150081. Braz J Cardiovasc Surg. 2015. PMID: 26934405 Free PMC article. Review.
Cited by
-
Beyond the cytoplasm: nuclear α-actin influences differentiation.Nat Cardiovasc Res. 2023 Oct;2(10):864-866. doi: 10.1038/s44161-023-00343-6. Nat Cardiovasc Res. 2023. PMID: 39196252 No abstract available.
-
Insights into the regulatory role of epigenetics in moyamoya disease: Current advances and future prospectives.Mol Ther Nucleic Acids. 2024 Jul 19;35(3):102281. doi: 10.1016/j.omtn.2024.102281. eCollection 2024 Sep 10. Mol Ther Nucleic Acids. 2024. PMID: 39188306 Free PMC article. Review.
-
Conserved regulatory switches for the transition from natal down to juvenile feather in birds.Nat Commun. 2024 May 16;15(1):4174. doi: 10.1038/s41467-024-48303-3. Nat Commun. 2024. PMID: 38755126 Free PMC article.
-
Unveiling cellular and molecular aspects of ascending thoracic aortic aneurysms and dissections.Basic Res Cardiol. 2024 Jun;119(3):371-395. doi: 10.1007/s00395-024-01053-1. Epub 2024 May 3. Basic Res Cardiol. 2024. PMID: 38700707 Free PMC article. Review.
-
Molecular Biomarkers Affecting Moyamoya Disease.Adv Tech Stand Neurosurg. 2024;49:1-18. doi: 10.1007/978-3-031-42398-7_1. Adv Tech Stand Neurosurg. 2024. PMID: 38700677
References
-
- Pepin M., Schwarze U., Superti-Furga A., Byers P.H. Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type. N. Engl. J. Med. 2000;342:673–680. - PubMed
-
- Friedman J.M., Arbiser J., Epstein J.A., Gutmann D.H., Huot S.J., Lin A.E., McManus B., Korf B.R. Cardiovascular disease in neurofibromatosis 1: Report of the NF1 Cardiovascular Task Force. Genet. Med. 2002;4:105–111. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous